A detailed history of State Street Corp transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 1,000,998 shares of RGLS stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000,998
Previous 967,502 3.46%
Holding current value
$1.4 Million
Previous $1.73 Million 9.24%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.46 - $1.9 $48,904 - $63,642
33,496 Added 3.46%
1,000,998 $1.57 Million
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.8 $1.66 Million - $2.59 Million
925,783 Added 2219.09%
967,502 $1.73 Million
Q2 2022

Aug 15, 2022

BUY
$1.6 - $3.4 $66,750 - $141,844
41,719 New
41,719 $86,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $20.5M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.